BSE filing, NSE: SAVFI. Summary written from the filing by ALFA Finder's alert engine.
Mantra Capital Ltd: key numbers
- Share price
- ₹16.51
- Market cap
- ₹59.15 Cr
- Revenue (annual)
- ₹16.32 Cr
- Net profit (annual)
- ₹-13.46 Cr
- P/E (TTM)
- -5.9×Sector 19.7×
- Promoter holding
- 67.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mantra Capital Ltd
All →Mantra Capital Convertible Warrants
No fund deviation reported on Mantra Capital's conversion of 15 lakh warrants into equity, worth ₹1.50 Crore. The warrants were issued to promoter MD Deepa Tracy.
- Value
- ₹1.50 Cr
Mantra Capital Q2 FY27 Results: Turns Profitable, Net Profit ₹1.8 Cr
Mantra Capital Ltd reported revenue from operations of ₹5.9 Cr (+73.5% YoY) and net profit of ₹1.8 Cr for Q2 FY27.
- Key figure
- Net profit ₹1.8 Cr
Mantra Capital Convertible Warrants
Mantra Capital allotted 30,00,000 equity shares to Mrs. Deepa Kishor Tracy upon conversion of warrants for ₹3 Crore.
- Value
- ₹3.00 Cr
Mantra Capital Board Meeting Date
Mantra Capital Limited has scheduled a board meeting for October 26, 2026. The board will consider unaudited standalone financial results for the half-year ended September 2026.
Mantra Capital Annual Report
Mantra Capital has resubmitted its Annual Report for FY 2025-26. The revision is limited only to changing the document layout to portrait orientation.
Mantra Capital Annual General Meeting
Mantra Capital Ltd concluded its 42nd Annual General Meeting on September 28, 2026, transacting ordinary and special business items, including the adoption of annual financial statements.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.